NCT07172152Completed
Improving Minority Health Through Biofeedback and Stress Reduction
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of a four-week heart rate variability (HRV) biofeedback intervention to improve physiological stress response, emotion regulation, and anxiety-related symptoms in young ethnic minority adults with a family history of cardiovascular disease (CVD). Participants will be randomly assigned to either an intervention group, where they will engage in guided paced breathing exercises, or a control group, which will follow standard conditions without the intervention. The study consists of five sessions, including an initial assessment, three weekly check-in sessions, and a final post-intervention assessment. Participants will practice paced breathing at home and attend brief in-lab sessions to track progress. Physiological and psychological measures, such as HRV, GSR, BP, anxiety levels, and responses to the Socially Evaluated Cold Pressor Test (SECPT), will be used to assess outcomes. Findings from this study may provide insights into accessible, non-invasive stress management interventions to mitigate CVD risk in high-risk populations.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 8 Sept 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Amelia Saul, PhD, CTRS, BCB
- Diseases
- High blood pressure
- NCT number
- NCT07172152
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From 15 Sept 2025 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously receiving biofeedback training
- Patients currently taking medications such as MAOIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone) are excluded due to their potential to affect the HRV data
Other illness
- Current diagnosis of hypertension that is controlled with prescribed medication
- Having a severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes)
- Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data
Other
- Cognitive impairments that inhibit understanding instruction
- Being actively psychotic
Who the study is looking for
- Adults
- Age 18 to 35 years
- Cognitively intact to follow instructions
- English-speaking
- Family history of cardiovascular disease.
Age in the registry: 18 years to 35 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Florida International University Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.